Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP)’s stock price rose 1.9% on Thursday . The company traded as high as $10.18 and last traded at $10.14. Approximately 1,109,122 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 3,016,769 shares. The stock had previously closed at $9.95. Analyst […]
HighMark Wealth Management LLC boosted its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 72.0% during the first quarter, Holdings Channel.com reports. The institutional investor owned 64,499 shares of the biotechnology company’s stock after purchasing an additional 27,000 shares during the period. Aurinia Pharmaceuticals accounts for approximately 0.6% of HighMark Wealth Management […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $9.16, but opened at $10.37. Aurinia Pharmaceuticals shares last traded at $9.97, with a volume of 1,882,306 shares changing hands. Analyst Ratings Changes Several research firms have commented on AUPH. StockNews.com […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 16,700,000 shares, a growth of 7.6% from the May 15th total of 15,520,000 shares. Based on an average trading volume of 2,950,000 shares, […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) Director David R.W. Jayne sold 8,733 shares of the stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $11.26, for a total transaction of $98,333.58. Following the transaction, the director now directly owns 49,310 shares in the company, valued […]